The Cancer Letter

Inside information on cancer research and drug development

Clinical

New Evidence-Based Guideline on HER2 Testing for Patients with Gastric Cancer 

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The College of American Pathologists, the American Society for Clinical Pathology, and the American Society of Clinical Oncology released an evidence-based clinical practice guideline on human epidermal growth factor receptor 2 testing for patients with gastroesophageal cancers.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Clinical Roundup

Neuro-oncology experts release clinical practice guidelines for using AI in brain cancer diagnosis, monitoring, treatment

An international, multidisciplinary team of leading neuro-oncology researchers and clinicians has released new recommendations for good clinical practice—a set of guidelines that helps ensure clinical trial results are reliable, and patients are protected—regarding the use of artificial intelligence methods to more accurately diagnose, monitor, and treat brain cancer patients. The team recently published two companion...

Clinical Roundup

Conventional age-based guidelines for CRC screening do not account for health status, life expectancy, UT Southwestern researchers find

Colorectal cancer screening rates are similar among older adults despite varying 10-year mortality risks, UT Southwestern Medical Center researchers report in a study. The findings, published in The American Journal of Gastroenterology, challenge conventional age-based recommendations for CRC screening that don’t take into account factors like individual life expectancies and comorbidities.
Table of Contents

Login

Site license subscribers:
Log in with your IP | Register a sponsored account